N4 PHARMA PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8265 GBX | -2.76% |
|
+14.00% | -2.76% |
| Apr. 18 | N4 Pharma sees potential in Nuvec delivery method for cancer treatment | AN |
| Apr. 18 | N4 Pharma’s In Vivo Testing Shows Nuvec’s Potential as Oral Delivery System | MT |
Chart calendar N4 Pharma Plc
3c824dfa9a7a7b0ffa319.FM_LrK5isz4RwEymYC_KpQ69DpGeFt5O5EOCG2QrFGg.evqI6sVbxFdLsgnDAhz-xj3QQfz_eLI3kHbpKQl7fQk5h-bY3Q3ibk61Iw~96d01704bb49bcadfc4bbe89eaaf176c
Upcoming events on N4 Pharma Plc
Past events on N4 Pharma Plc
| 2023-10-16 09:00 am | Acquisition of Nanogenics Ltd by N4 Pharma Plc Call |
| 2023-09-12 02:00 am | Q2 2023 Earnings Release |
| 2023-04-03 06:00 am | Annual General Meeting |
| 2023-03-09 02:00 am | Q4 2022 Earnings Release |
| 2022-09-29 02:00 am | Interim 2022 Earnings Release |
| 2022-03-24 07:00 am | Annual General Meeting |
| 2022-02-23 02:00 am | FY 2021 Earnings Release |
| 2021-09-20 02:00 am | Interim 2021 Earnings Release |
| 2021-03-24 06:00 am | Annual General Meeting |
| 2021-02-24 02:00 am | FY 2020 Earnings Release |
| 2020-09-17 02:30 am | Interim 2020 Earnings Release |
| 2020-06-18 05:00 am | Shareholders Meeting |
| 2020-04-23 05:00 am | Annual General Meeting |
| 2020-02-25 02:00 am | FY 2019 Earnings Release |
| 2019-09-18 02:00 am | Interim 2019 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 |
|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,07 | 0,00 0,00 - |
|
EBITDA Million GBP | Released Forecast Spread | 0,00 | -0,95 -1,09 12.85% |
|
EBIT Million GBP | Released Forecast Spread | 0,00 | -0,95 -1,09 12.85% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - |
|
Net income | Released Forecast Spread | 0,00 | 0,00 0,00 - |
|
EPS | Released Forecast Spread | 0,00 | 0,00 0,00 - |
| Announcement Date | 14/05/19 | 25/02/20 |
More events
Past sector events for N4 Pharma Plc
- Stock Market
- Equities
- ONZ Stock
- Calendar N4 Pharma Plc
